Modeling Oculopharyngeal Muscular Dystrophy in Myotube Cultures Reveals Reduced Accumulation of Soluble Mutant PABPN1 Protein
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The insoluble PABPN1 and polyadenylated RNA puncta we detected in Ala17 PABPN1-TurboID expressing myotubes may represent stalled RNA processing complexes that later develop into aggregates, which have previously been described as pre-intranuclear inclusions (INI) [45].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Altered proteasome structure, function, and oxidation in aged muscle.
Ferrington, D. A., Husom, A. D., & Thompson, L. V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2578fje · Cited by 259
Davies, J. E., Sarkar, S., & Rubinsztein, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi422 · Cited by 207
Research works printed but not linked: 53
- Cummings, 2000, Fourteen and counting: unraveling trinucleotide repeat diseases, Hum Mol Genet, 9, 909, 10.1093/hmg/9.6.909 · DOI · Paper page
- Albrecht, 2005, The other trinucleotide repeat: polyalanine expansion disorders, Curr Opin Genet Dev, 15, 285, 10.1016/j.gde.2005.04.003 · DOI · Paper page
- Brown, 2004, Alanine tracts: the expanding story of human illness and trinucleotide repeats, Trends Genet, 20, 51, 10.1016/j.tig.2003.11.002 · DOI · Paper page
- Ross, 2004, Protein aggregation and neurodegenerative disease, Nat Med, 10, S10, 10.1038/nm1066 · DOI · Paper page
- Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat Genet, 18, 164, 10.1038/ng0298-164 · DOI · Paper page
- Wahle, 1991, A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation, Cell, 66, 759, 10.1016/0092-8674(91)90119-J · DOI · Paper page
- Wahle, 1995, 3′-end cleavage and polyadenylation of mRNA precursors, Biochim Biophys Acta, 1261, 183, 10.1016/0167-4781(94)00248-2 · DOI
- Bouchard, 1997, Recent studies on oculopharyngeal muscular dystrophy in Quebec, Neuromuscul Disord, 7, S22, 10.1016/S0960-8966(97)00077-1 · doi:10.1016/s0960-8966(97)00077-1
- Taylor, 1915, Progressive vagus-glossopharyngeal paralysis with ptosis: contribution the group of family diseases, J Nerv Ment Dis, 42, 129, 10.1097/00005053-191503000-00001 · doi:10.1097/00005053-191503000-00001
- Calado, 2000, Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA, Hum Mol Genet, 9, 2321, 10.1093/oxfordjournals.hmg.a018924 · DOI · Paper page
- Tome, 1980, Nuclear inclusions in oculopharyngeal dystrophy, Acta Neuropathol, 49, 85, 10.1007/BF00692226 · DOI
- Tome, 1997, Morphological changes in muscle fibers in oculopharyngeal muscular dystrophy, Neuromuscul Disord, 7, S63, 10.1016/S0960-8966(97)00085-0 · DOI
- Berciano, 2004, Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus, Hum Mol Genet, 13, 829, 10.1093/hmg/ddh101 · DOI
- Villagra, 2008, Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions, Mol Cell Neurosci, 37, 622, 10.1016/j.mcn.2007.12.012 · DOI
- Klein, 2008, PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression, Exp Cell Res, 314, 1652, 10.1016/j.yexcr.2008.02.005 · doi:10.1016/j.yexcr.2008.02.005
- Tavanez, 2005, In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1, RNA, 11, 752, 10.1261/rna.7217105 · DOI
- Chartier, 2006, A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1, EMBO J, 25, 2253, 10.1038/sj.emboj.7601117 · DOI · Paper page
- Brais, 2009, Oculopharyngeal muscular dystrophy: a polyalanine myopathy, Curr Neurol Neurosci Rep, 9, 76, 10.1007/s11910-009-0012-y · DOI
- Catoire, 2008, Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1, Hum Mol Genet, 17, 2108, 10.1093/hmg/ddn109 · DOI · Paper page
- Davies, 2005, Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice, Nat Med, 11, 672, 10.1038/nm1242 · DOI · Paper page
- Chartier, 2009, Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo, Hum Mol Genet, 18, 1849, 10.1093/hmg/ddp101 · DOI
- Trollet, 2010, Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres, Hum Mol Genet, 19, 2191, 10.1093/hmg/ddq098 · DOI
- Blumen, 1999, Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease, Ann Neurol, 46, 115, 10.1002/1531-8249(199907)46:1<115::AID-ANA17>3.0.CO;2-O · doi:10.1002/1531-8249(199907)46:1<115::aid-ana17>3.0.co;2-o
- Hino, 2004, Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy, Hum Mol Genet, 13, 181, 10.1093/hmg/ddh017 · DOI
- Apponi, 2010, Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis, Hum Mol Genet, 19, 1058, 10.1093/hmg/ddp569 · DOI · Paper page
- Kim, 2001, The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression, Hum Mol Genet, 10, 1129, 10.1093/hmg/10.11.1129 · DOI
- Wang, 2006, Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis, Biochem Biophys Res Commun, 340, 815, 10.1016/j.bbrc.2005.12.078 · doi:10.1016/j.bbrc.2005.12.078
- Anvar, 2011, Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients, Skelet Muscle, 1, 15, 10.1186/2044-5040-1-15 · DOI
- Needham, 1995, Further development of the locus control region/murine erythroleukemia expression system: high level expression and characterization of recombinant human calcitonin receptor, Protein Expr Purif, 6, 124, 10.1006/prep.1995.1015 · doi:10.1006/prep.1995.1015
- Tam, 2006, The human desmin locus: gene organization and LCR-mediated transcriptional control, Genomics, 87, 733, 10.1016/j.ygeno.2006.01.009 · DOI
- Chubet, 1996, Vectors for expression and secretion of FLAG epitope-tagged proteins in mammalian cells, Biotechniques, 20, 136, 10.2144/96201pf01 · DOI
- Morgan, 1994, Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines, Dev Biol, 162, 486, 10.1006/dbio.1994.1103 · DOI · Paper page
- Carmeli, 2002, The biochemistry of aging muscle, Exp Gerontol, 37, 477, 10.1016/S0531-5565(01)00220-0 · DOI · Paper page
- Goeman, 2004, A global test for groups of genes: testing association with a clinical outcome, Bioinformatics, 20, 93, 10.1093/bioinformatics/btg382 · DOI · Paper page
- Raz, 2006, Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells, J Cell Sci, 119, 4247, 10.1242/jcs.03180 · DOI
- Verheesen, 2006, Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody, Hum Mol Genet, 15, 105, 10.1093/hmg/ddi432 · DOI
- Abu-Baker, 2003, Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy, Hum Mol Genet, 12, 2609, 10.1093/hmg/ddg293 · DOI
- Bao, 2004, Congo red, doxycycline, and HSP70 overexpression reduce aggregate formation and cell death in cell models of oculopharyngeal muscular dystrophy, J Med Genet, 41, 47, 10.1136/jmg.2003.014548 · DOI
- Corbeil-Girard, 2005, PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions, Neurobiol Dis, 18, 551, 10.1016/j.nbd.2004.10.019 · DOI
- Klein, 2008, PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression, Exp Cell Res, 314, 1652, 10.1016/j.yexcr.2008.02.005 · doi:10.1016/j.yexcr.2008.02.005
- Messaed, 2007, Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy, Neurobiol Dis, 26, 546, 10.1016/j.nbd.2007.02.004 · DOI
- Antoniou, 1998, Efficient 3′-end formation of human beta-globin mRNA in vivo requires sequences within the last intron but occurs independently of the splicing reaction, Nucleic Acids Res, 26, 721, 10.1093/nar/26.3.721 · DOI · Paper page
- Collis, 1990, Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression, EMBO J, 9, 233, 10.1002/j.1460-2075.1990.tb08100.x · DOI · Paper page
- Custodio, 1999, Inefficient processing impairs release of RNA from the site of transcription, EMBO J, 18, 2855, 10.1093/emboj/18.10.2855 · DOI · Paper page
- Millevoi, 2002, A novel function for the U2AF 65 splicing factor in promoting pre-mRNA 3′-end processing, EMBO Rep, 3, 869, 10.1093/embo-reports/kvf173 · DOI
- Davies, 2008, Wild-type PABPN1 is anti-apoptotic and reduces toxicity of the oculopharyngeal muscular dystrophy mutation, Hum Mol Genet, 17, 1097, 10.1093/hmg/ddm382 · DOI
- Fan, 2001, Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death, Hum Mol Genet, 10, 2341, 10.1093/hmg/10.21.2341 · DOI
- Hjerpe, 2009, Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities, EMBO Rep, 10, 1250, 10.1038/embor.2009.192 · DOI · Paper page
- Lemay, 2010, Crossing the borders: poly(A)-binding proteins working on both sides of the fence, RNA Biol, 7, 291, 10.4161/rna.7.3.11649 · DOI
- Kuhn, 2004, Structure and function of poly(A) binding proteins, Biochim Biophys Acta, 1678, 67, 10.1016/j.bbaexp.2004.03.008 · DOI · Paper page
- Kühn, 2009, Poly(A) tail length is controlled by the nuclear poly(A)-binding protein regulating the interaction between poly(A) polymerase and the cleavage and polyadenylation specificity factor, J Biol Chem, 284, 22803, 10.1074/jbc.M109.018226 · DOI · Paper page
- Junghans, 2009, Dystrophia myotonia: why focus on foci?, Eur J Hum Genet, 17, 543, 10.1038/ejhg.2008.227 · DOI
- de Mezer, 2011, Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference, Nucleic Acids Res, 39, 3852, 10.1093/nar/gkq1323 · DOI · Paper page
Cited by
Mezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E. (2026) · PLOS Genetics · doi:10.1371/journal.pgen.1011743 · Cited by 7
Metadata
- Authors
- Raz, V., Routledge, S., Venema, A., Buijze, H., van der Wal, E., Anvar, S., Straasheijm, K. R., Klooster, R., Antoniou, M., & van der Maarel, S. M.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 179
- Issue
- 4
- Pages
- 1988-2000
- ISSN
- 0002-9440
- Cited by
- 42
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2995 d)
- Funders
- Muscular Dystrophy Association (68015)
- European Commission (POLYALA LSHM-CT-2005-018675, TRI-EX QLG2-CT-2001-01673)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modeling Oculopharyngeal Muscular Dystrophy in Myotube Cultures Reveals Reduced Accumulation of Soluble Mutant PABPN1 Protein. https://app.cochat.ai/papers/10.1016/j.ajpath.2011.06.044
- The paper
- Raz, V., Routledge, S., Venema, A., Buijze, H., van der Wal, E., Anvar, S., Straasheijm, K. R., Klooster, R., Antoniou, M., & van der Maarel, S. M. (2011). Modeling Oculopharyngeal Muscular Dystrophy in Myotube Cultures Reveals Reduced Accumulation of Soluble Mutant PABPN1 Protein. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2011.06.044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.